Patents by Inventor Gerald HOCHLEITNER

Gerald HOCHLEITNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11744880
    Abstract: The invention pertains to a blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings of patients having an acquired coagulation factor deficiency or for use in the treatment or prophylaxis of bleedings of patients having a congenital deficiency of a coagulation factor. Said product comprises at least isolated prothrombin (Factor II) and isolated Antithrombin III (ATIII), whereby the molar ratio between ATIII to Factor II is at least 1:30. By administration of said product the patient's risk for a thromboembolic complication is reduced.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: September 5, 2023
    Assignee: CSL Behring GmbH
    Inventors: Eva Herzog, Gerald Hochleitner, Oliver Grottke
  • Publication number: 20190351028
    Abstract: The invention pertains to a blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings of patients having an acquired coagulation factor deficiency or for use in the treatment or prophylaxis of bleedings of patients having a congenital deficiency of a coagulation factor. Said product comprises at least isolated prothrombin (Factor II) and isolated Antithrombin III (ATIII), whereby the molar ratio between ATIII to Factor II is at least 1:30. By administration of said product the patient's risk for a thromboembolic complication is reduced.
    Type: Application
    Filed: February 9, 2018
    Publication date: November 21, 2019
    Inventors: Eva HERZOG, Gerald HOCHLEITNER, Oliver GROTTKE